Metabolic and Vascular Physiology Laboratory, Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia.
Pharmacol Ther. 2013 Oct;140(1):26-33. doi: 10.1016/j.pharmthera.2013.05.009. Epub 2013 May 26.
Harnessing the considerable capacity of brown adipose tissue (BAT) to consume energy was first proposed as a potential target to control obesity nearly 40years ago. The plausibility of this approach was, however, questioned due to the prevailing view that BAT was either not present or not functional in adult humans. Recent definitive identification of functional BAT in adult humans as well as a number of important advances in the understanding of BAT biology has reignited interest in BAT as an anti-obesity target. Proof-of-concept evidence demonstrating drug-induced BAT activation provides an important foundation for development of targeted pharmacological approaches with clinical application. This review considers evidence from both human and relevant animal studies to determine whether harnessing BAT for the treatment of obesity via pharmacological intervention is a realistic goal.
将近 40 年前,人们首次提出利用棕色脂肪组织(BAT)的巨大能量消耗能力来控制肥胖,这是一个潜在的目标。然而,由于普遍认为 BAT 在成年人体内不存在或不起作用,这种方法的可行性受到了质疑。最近,人们明确地在成年人体内发现了具有功能的 BAT,并且对 BAT 生物学的理解也取得了一些重要进展,这重新激起了人们对 BAT 作为抗肥胖靶点的兴趣。证明药物诱导 BAT 激活的概念验证证据为开发具有临床应用的靶向药理方法提供了重要基础。这篇综述综合了来自人体和相关动物研究的证据,以确定通过药物干预利用 BAT 治疗肥胖是否是一个现实的目标。